1087 SOT201 is a novel cis-acting immunocytokine targeting IL-15Rβγ to reinvigorate PD-1+tumor infiltrating lymphocytes and potentiate anti-tumor efficacy

Irena Adkins; Zuzana Antosova; Katerina Behalova; Petr Danek; Klara Danova; Matej Fabisik; Kamila Hladikova; Nataliia Kalynovska; Lucie Kosinova; Pavel Marasek; Vladyslav Mazhara; Nada Podzimkova; Jan Praslicka; Katerina Sajnerova; Milada Sirova; David Bechard; Ulrich Moebius; Marek Kovar; Lenka Palova Jelinkova; Radek Spisek; Martin Steegmaier

doi:10.1136/jitc-2023-SITC2023.1087

Citation Tools

Regular and Young Investigator Award Abstracts

Immune-Stimulants and Immune Modulators

1087 SOT201 is a novel cis-acting immunocytokine targeting IL-15Rβγ to reinvigorate PD-1⁺tumor infiltrating lymphocytes and potentiate anti-tumor efficacy

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Cite this article as:: Adkins I, Antosova Z, Behalova K, et al

1087 SOT201 is a novel cis-acting immunocytokine targeting IL-15Rβγ to reinvigorate PD-1⁺tumor infiltrating lymphocytes and potentiate anti-tumor efficacy

Journal for ImmunoTherapy of Cancer 2023;11:doi: 10.1136/jitc-2023-SITC2023.1087

Log in using your username and password

Main menu

Log in using your username and password

You are here

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password